Your session is about to expire
← Back to Search
Team-based Care for High Blood Pressure
N/A
Waitlist Available
Led By Donna Shelley, MD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Minimum of 2 non-physician staff available at any time
Have a minimum of 200 patients on their practice panels that have hypertension that are managed by the practice
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial compares how well team-based care works in 90 primary care practices with and without extra help.
Who is the study for?
This trial is for small-to-medium primary care practices with 1-5 healthcare providers and at least 2 non-physician staff. They must use an EHR system, have over 200 patients with hypertension, not be involved in other CVD initiatives, and agree to a 'physician champion' leading the intervention.Check my eligibility
What is being tested?
The study tests Practice Facilitation's impact on adopting team-based care for managing high blood pressure within independent primary care practices. It randomly assigns when each practice starts the intervention in a stepped-wedge design.See study design
What are the potential side effects?
Since this trial involves organizational changes rather than medical treatments, there are no direct side effects like those seen with medications. However, there may be indirect impacts on workflow or staff satisfaction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My care team includes at least 2 non-physician staff members available.
Select...
My practice manages hypertension for at least 200 patients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of practices that adopt team-based care as assessed by the Primary Care Team Dynamic Survey and Team Process - Monitoring Progress Toward Goals sub-scale.
Secondary outcome measures
Percentage of with a diagnosis of hypertension who have a BP <140/90 (JNC Guidelines) as assessed through EHRs reports.
Trial Design
2Treatment groups
Active Control
Group I: Practice FacilitationActive Control1 Intervention
Practices review coaching and support from a trained practice facilitator. This includes 24 site visits in which facilitators meet with staff to work on implementing system changes to improve hypertension management.
Group II: Current PracticeActive Control1 Intervention
Practices will deliver care as usual and patients at these sites receive standard HTN care delivered.
Find a Location
Who is running the clinical trial?
New York UniversityLead Sponsor
226 Previous Clinical Trials
314,174 Total Patients Enrolled
New York City Department of Health and Mental HygieneOTHER_GOV
18 Previous Clinical Trials
18,452 Total Patients Enrolled
Donna Shelley, MDPrincipal InvestigatorNYU School of Global Public Health
3 Previous Clinical Trials
386 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My care team includes at least 2 non-physician staff members available.My practice manages hypertension for at least 200 patients.My doctor's practice manages fewer than 200 patients with high blood pressure.You are currently involved in or planning to join another program to improve cardiovascular health during the study.My healthcare provider lacks the staff for team-based care.
Research Study Groups:
This trial has the following groups:- Group 1: Practice Facilitation
- Group 2: Current Practice
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any new participants being enrolled at this time in the clinical trial?
"Unfortunately, according to clinicaltrials.gov, this medical research is not currently in need of participants. The trial was originally posted on January 31st 2023 and last amended on April 28th 2023. Although no longer recruiting patients for this study, there are 1113 other trials that are still enrolling subjects at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger